## ⚠ Content Warning This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here. --- last_verified: "2026-05-20T08:12:33.937Z" --- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "GoodRx: Prescription Coupons" developer_entity: "GoodRx" bundle_id: "com.goodrx" category: "Medical" primary_platform: "android" primary_monetization: "Freemium" offline_capable: false market_region: "US" platforms: "Android" app_last_updated: "2026-05-19" report_date: "2026-05-20" last_verified: "2026-05-20" report_version: "8.104.2" total_reviews: 334407 overall_rating: 4.81 sentiment: "Excited" sentiment_score: 85 confidence: "high" confidence_score: 0.7 top_praise_theme: "Significant out-of-pocket prescription cost reductions provide essential financial relief for uninsured users" top_complaint_theme: "Automated payment processing failures for treatment plans cause significant user frustration" review_sample_size: 50 total_review_count: 50 analyzed_review_count: 50 data_age_days: 0 momentum_velocity: "maintenance" intelligence_version: 3 nemesis: "SingleCare Rx Pharmacy Coupons" competitor_count: 10 tags: ["medical", "freemium", "excited sentiment", "mobile app", "app review", "app analysis", "individuals", "seeking", "affordable"] canonical_url: "https://marlvel.ai/intel-report/medical/com-goodrx" license: "CC-BY-NC 4.0" content_version: "v2" --- # GoodRx: Prescription Coupons App Audit ## TL;DR {#tldr} - **Category**: Medical · Freemium - **Signal**: Rating 4.81 · Sentiment Excited - **Recent focus**: Automated payment processing failures for treatment plans cause significant user frustration (top complaint) · Significant out-of-pocket prescription cost reductions provide essential financial relief for uninsured users (top praise) > **TL;DR:** GoodRx: Prescription Coupons is a medical app by GoodRx, rated 4.81/5 by 334.4K users, with Excited user sentiment (85/100), available on Android. > > **Marlvel.ai App Intelligence** — Independent analysis. US Market. No publisher influence. > **Key Insight:** GoodRx: Prescription Coupons maintains Excited user sentiment (4.81/5 from 334.4K reviews), with users consistently praising significant out-of-pocket prescription cost reductions provide essential financial relief for uninsured users. ## Quick Facts | Fact | Value | | :--- | :--- | | **Rating** | 4.81/5 (334.4K reviews) | | **User Mood** | Excited | | **Category** | Medical | | **Developer** | GoodRx | | **Pricing** | Freemium | | **Platforms** | Android | | **Confidence** | High (0.7/1.0) | | **Data Age** | 0d | ## Metadata & Market Performance - **Publisher:** GoodRx - **Category:** Medical - **Target Audience:** Individuals seeking affordable prescription medications and virtual healthcare services without reliance on traditional health insurance. - **Platforms:** Android - **Version Audited:** 8.104.2 - **Audit Date:** 2026-05-20 - **Signal Count:** 50 reviews analyzed - **Confidence:** High (0.7/1.0) - **Google Play ID:** com.goodrx - **Performance Trend:** Mixed - **Data Window:** Analysis based on signals collected up to 2026-05-20 - **Short Description:** Find affordable prescription medications for you and your family with GoodRx. ## Executive Snapshot **What it is:** GoodRx is a medical app providing prescription discount coupons and telehealth services for uninsured patients on iOS and Android. **Why users hire it:** Users hire GoodRx to bypass high out-of-pocket pharmacy costs and access virtual care without traditional insurance, serving as a financial lifeline. ## App DNA (Features & Intent) - **[Differentiator] Prescription Discount Coupons:** Digital coupons for pharmacy medication purchases at over 70,000 locations - **[Differentiator] GoodRx Care Direct:** Subscription-based telehealth visits for weight loss, birth control, and short-term medication refills * *User Intent:* Users seek enhanced value through premium features. - **[Standard] Medication Tracker and Reminders:** In-app pill tracker and alert system for daily prescription management * *User Intent:* Users are motivated by consistent progression and daily incentives. - **[Standard] Drug Price Comparison:** Real-time price checking across multiple pharmacy chains for specific medications * *User Intent:* Users expect intelligent, adaptive experiences that learn from their behavior. ## Market Position {#market-position} GoodRx holds the #4 Free position in the US Medical category, maintaining this rank through a broad pharmacy network that independent discount apps cannot replicate. The gap between its free coupon utility and the paid telehealth subscription tier remains the primary friction point for user conversion. ## Monetization Strategy - **Model:** Freemium - **Tiers:** Free digital coupons and medication tracking, Subscription-based telehealth access via GoodRx Care Direct - **Analysis:** Freemium model combines free-to-use pharmacy discount tools with paid subscription access for virtual medical consultations. ## 🟢 User Sentiment (High Confidence: 50 of 50 reviews analyzed) {#user-sentiment} - **Overall Rating:** 4.81/5 - **Platform Split:** Android 4.8/5 (334.4K ratings) - **Overall Sentiment:** Excited ### Top Praises - **Significant out-of-pocket prescription cost reductions provide essential financial relief for uninsured users** - **Simplified interface design allows for quick and efficient pharmacy price comparisons** ### Top Complaints (Impact Areas) - **Automated payment processing failures for treatment plans cause significant user frustration** - **Perceived lack of transparency regarding additional service fees and hidden costs** ## SWOT Analysis {#swot} **Core Strengths:** - 70,000-pharmacy network functions as a B2B distribution moat - High-intent traffic drives consistent affiliate revenue - Integrated telehealth subscription creates a secondary recurring revenue stream **Critical Frictions:** - Automated payment processing failures for treatment plans - Perceived lack of transparency regarding service fees - Technical instability at the point of sale **Growth Levers:** - Expansion of pet medication discounts - Untapped B2B partnerships with independent clinics - Deeper integration of wearable health data **Market Threats:** - PBM-controlled pharmacy benefit layers - Direct-to-door delivery models from NimbleRx - Specialized telehealth pure-plays like Teladoc ## Recent Changes (v2 → v3) {#recent-changes} GoodRx transitioned to a freemium model by gating telehealth services behind a subscription, while simultaneously surfacing new technical and transparency-related user complaints. **Overall trend**: Mixed **Compared at**: 2026-05-20 ### High-impact changes - **[Shifted] Freemium Model Adoption** (pricing) — Pricing model shifted from free-only to freemium, introducing a paid subscription tier for GoodRx Care Direct telehealth services. - **[Declined] Emergence of Payment and Transparency Complaints** (sentiment) — New user complaints surfaced regarding automated payment processing failures and lack of transparency in service fees. ### Medium-impact changes - **[Improved] Feature Repositioning** (features) — Prescription coupons and telehealth services were reclassified from 'standard' to 'differentiator' competitive positions. - **[Added] New SWOT Risk Factors** (swot) — Added technical instability at the point of sale and PBM-controlled pharmacy benefit layers as identified weaknesses and threats. ## Rivals Landscape {#rivals} > Competitive positioning identified by AI analysis of app features, category, and market signals. ### GoodRx: Prescription Coupons vs SingleCare Rx Pharmacy Coupons — Head to Head - **[SingleCare Rx Pharmacy Coupons](https://marlvel.ai/intel-report/medical/com-singlecare-singlecare)** by SingleCare: SingleCare operates in the exact same prescription discount niche with a high-velocity release cadence, directly challenging GoodRx's core value proposition. - **Moat strength:** Medium — durable but contestable - **Key differences:** - Focuses exclusively on pharmacy discount transparency without the broader telehealth ecosystem overhead found in GoodRx. - Maintains a high release frequency of 5 updates in six months to optimize coupon redemption flows. - Directly targets the uninsured and underinsured demographic with a simplified, single-purpose coupon interface. - **Where GoodRx: Prescription Coupons wins:** - ✅ Offers a more comprehensive health ecosystem by integrating telehealth services and a medication tracker alongside discounts. - ✅ Provides a broader drug guide and educational content to support long-term medication adherence beyond just price savings. - **Where SingleCare Rx Pharmacy Coupons wins:** - ❌ Delivers a streamlined, single-purpose user experience that reduces friction for users seeking immediate pharmacy savings. - ❌ Maintains a highly focused brand identity that avoids the feature bloat associated with multi-service medical platforms. - **Verdict:** GoodRx must defend its position by emphasizing the value of its integrated telehealth and tracking features to prevent users from migrating to simpler, discount-only alternatives. ### Contenders (Strong Challengers) - **[NimbleRx](https://marlvel.ai/intel-report/medical/com-nimblerx-nimblerx)** by NimbleRx [Moat: Medium]: NimbleRx is a high-velocity competitor that has shipped 26 updates in six months, indicating an aggressive focus on pharmacy delivery and fulfillment. - Integrates direct-to-door prescription delivery services which shifts the value proposition from couponing to full-service pharmacy fulfillment. - Maintains an extremely high update cadence to rapidly iterate on delivery logistics and pharmacy network connectivity. - **[Express Scripts](https://marlvel.ai/intel-report/medical/com-medco-medcopharmacy)** by Express Scripts [Moat: High]: As a major PBM, Express Scripts controls the pharmacy benefit layer, creating a structural competitive barrier for independent discount apps. - Leverages deep integration with insurance plan formularies to provide personalized pricing that discount apps cannot replicate. - Provides a closed-loop experience for members that prioritizes mail-order pharmacy utilization over retail coupon usage. - **[OptumRx](https://marlvel.ai/intel-report/medical/com-optumhealth-mobile-optumrx)** by Optum Inc. [Moat: High]: OptumRx represents a significant institutional competitor that leverages its position within the UnitedHealth ecosystem to capture pharmacy spend. - Offers deep integration with clinical health records and insurance benefits to provide a unified pharmacy management experience. - Focuses on automated refill management and adherence tools that lock users into their proprietary pharmacy network. - **[CVS Caremark](https://marlvel.ai/intel-report/medical/com-caremark-caremark)** by CVS Caremark [Moat: High]: CVS Caremark leverages its massive physical retail footprint to create a hybrid digital-physical pharmacy experience that discount apps lack. - Provides seamless integration between digital prescription management and in-store pickup at thousands of physical locations. - Utilizes the CVS retail ecosystem to offer additional health services and loyalty rewards that drive platform stickiness. ### Peers (What They Do Better) - **[Teladoc Health](https://marlvel.ai/intel-report/medical/com-teladoc-members)** by Teladoc: Teladoc is a peer in the broader digital health space, focusing on the telehealth component of GoodRx's service offering. - Operates as a pure-play telehealth provider with a massive network of licensed physicians and specialists. - Provides a more robust virtual care experience compared to the secondary telehealth features found in GoodRx. - **[Zocdoc - Find and book doctors](https://marlvel.ai/intel-report/medical/com-zocdoc-zocdociphone)** by Zocdoc Inc: Zocdoc competes in the medical access space by facilitating doctor discovery and appointment booking. - Focuses on the front-end of the patient journey by simplifying the process of finding and booking in-person care. - Maintains a highly active development cycle to improve search filters and provider availability transparency. - **[Medisafe Medication Management](https://marlvel.ai/intel-report/medical/com-medisafe-medisafe)** by MediSafe Inc.: Medisafe is a peer in the medication adherence space, focusing on the tracker functionality GoodRx offers. - Specializes in complex medication adherence tools, including pill reminders and drug interaction warnings, which exceed GoodRx's basic tracking. - Provides a dedicated focus on patient health outcomes through behavioral nudges and family caregiver support features. - **[Sydney Health](https://marlvel.ai/intel-report/medical/com-anthem-sydneyhealth)** by Elevance Health, Inc: Sydney Health is a peer in the insurance-integrated health management space, serving as a comprehensive portal for members. - Acts as a centralized hub for insurance benefits, claims, and provider search, creating a high-barrier ecosystem for users. - Leverages deep member data to provide personalized health insights and care coordination that independent apps cannot access. ### New Kids on the Block (What's Innovative) - **[Spruce: Medical Communication](https://marlvel.ai/intel-report/medical/com-sprucehealth-messenger-live)** by Spruce Health: Spruce is an emerging threat in the medical communication space, showing consistent updates and a focus on provider-patient connectivity. ## What's New - **Latest (v8.104.2, today):** General app updates and performance improvements. ## App Momentum (Maintenance) {#momentum} - Ships stability improvements in latest release. - Maintains #4 Medical category rank. > **Cadence:** 1 total versions · 0 majors in last 6 months · 0 days since last update ## The "So What?" (Strategic Takeaway) {#so-what} GoodRx: Prescription Coupons is a market-leading medical app that is free with in-app purchases. With a 4.81/5 rating from 334.4K reviews, it delivers strong user satisfaction. > **Bottom Line:** GoodRx dominates the prescription discount space through its massive pharmacy network, but payment friction in its telehealth tier threatens long-term retention, so the PM must prioritize payment-flow reliability to secure recurring subscription revenue. **Best for:** Individuals seeking affordable prescription medications and virtual healthcare services without reliance on traditional health insurance. ### PM Action Plan (Next Best Moves) - [ ] [PIVOT] [HIGH IMPACT] Rebuild payment retry logic because payment failures are a top-3 complaint → reduce churn — *Automated payment processing failures are the primary complaint theme in user sentiment data.* _(trade-off: deprioritize Pause the new pet-medication discount feature sprint to Q3.)_ - [ ] [MAINTAIN] [MEDIUM IMPACT] Audit fee disclosure UI because transparency complaints erode brand trust → improve conversion — *Users report dissatisfaction with final pricing differing from initial estimates.* _(trade-off: deprioritize Same-quarter capacity available — no major lever displaced.)_ ### Feature Gaps vs Competitors - Direct-to-door prescription delivery (available in NimbleRx but absent here) - Deep insurance formulary integration (available in Express Scripts but absent here) ### Outlook: Stable The digital pharmacy market is consolidating around integrated fulfillment models, leaving coupon-only apps like GoodRx exposed to PBM-led competition. GoodRx must transition its user base from transactional coupon usage to recurring telehealth subscriptions to maintain its market position, so the PM should prioritize payment reliability to prevent churn. - 🔴 Payment processing failures in the latest version cause recurring user frustration, which risks long-term subscription retention. - 🟢 High-intent traffic for pharmacy discounts remains a strong engagement loop, securing the app's position against discount-only rivals. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Overall Rating | 4.81/5 | | Total Reviews | 334.4K | | Sentiment | Excited (85/100) | | Confidence | High | | Pricing Model | Freemium | | Platforms | Android | | Key Features | 4 analyzed | | Trend | Mixed | | Outlook | Stable | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **GoodRx: Prescription Coupons** (this app) | 4.81/5 | Excited | GoodRx | | [Express Scripts](https://marlvel.ai/intel-report/medical/com-medco-medcopharmacy) | 4.7/5 | Mixed | Express Scripts | | [NimbleRx](https://marlvel.ai/intel-report/medical/com-nimblerx-nimblerx) | 4.9/5 | N/A | NimbleRx | | [CVS Caremark](https://marlvel.ai/intel-report/medical/com-caremark-caremark) | 4.4/5 | N/A | CVS Caremark | | [Medisafe Medication Management](https://marlvel.ai/intel-report/medical/com-medisafe-medisafe) | 4.7/5 | Upset | MediSafe Inc. | | [Zocdoc - Find and book doctors](https://marlvel.ai/intel-report/medical/com-zocdoc-zocdociphone) | 4.9/5 | N/A | Zocdoc Inc | ## Company Profile - **Developer:** GoodRx - **Website:** [https://www.goodrx.com](https://www.goodrx.com) ## Data Sources & Links - **Google Play:** [View on Google Play](https://play.google.com/store/apps/details?id=com.goodrx) - **Dev Site:** [Official Website](https://www.goodrx.com) - **Sources:** Developer website content, App store metadata, User reviews. ## Related Intel Reports - [*Express Scripts*](https://marlvel.ai/intel-report/medical/com-medco-medcopharmacy) (Express Scripts) — 4.7/5 Rating | Mixed Sentiment - [*NimbleRx*](https://marlvel.ai/intel-report/medical/com-nimblerx-nimblerx) (NimbleRx) — 4.9/5 Rating | N/A Sentiment - [*CVS Caremark*](https://marlvel.ai/intel-report/medical/com-caremark-caremark) (CVS Caremark) — 4.4/5 Rating | N/A Sentiment - [*Medisafe Medication Management*](https://marlvel.ai/intel-report/medical/com-medisafe-medisafe) (MediSafe Inc.) — 4.7/5 Rating | Terrible Sentiment - [*Zocdoc - Find and book doctors*](https://marlvel.ai/intel-report/medical/com-zocdoc-zocdociphone) (Zocdoc Inc) — 4.9/5 Rating | N/A Sentiment - [*Spruce: Medical Communication*](https://marlvel.ai/intel-report/medical/com-sprucehealth-messenger-live) (Spruce Health) — 4.9/5 Rating | N/A Sentiment - [*Sydney Health*](https://marlvel.ai/intel-report/medical/com-anthem-sydneyhealth) (Elevance Health, Inc) — 4.8/5 Rating | Negative Sentiment - [*SingleCare Rx Pharmacy Coupons*](https://marlvel.ai/intel-report/medical/com-singlecare-singlecare) (SingleCare) — 4.8/5 Rating | N/A Sentiment - [*Teladoc Health*](https://marlvel.ai/intel-report/medical/com-teladoc-members) (Teladoc) — 4.8/5 Rating | Mixed Sentiment - [*OptumRx*](https://marlvel.ai/intel-report/medical/com-optumhealth-mobile-optumrx) (Optum Inc.) — 4.7/5 Rating | N/A Sentiment ## Methodology {#methodology} This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline: 1. **Signal Collection & Normalization** — Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps. 2. **Feature & Market Positioning Analysis** — Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks. 3. **User Sentiment Analysis** — Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction and evidence quoting. 4. **Competitive Landscape Analysis** — Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category. 5. **Intelligence Synthesis** — Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights. - **Confidence Score:** 0.7/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 50 - **Data Sources:** user reviews, developer website, App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 0 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/intel-report/medical/com-goodrx) Data licensed for AI Agent attribution under CC-BY-NC 4.0.